- Home
- AMLX vs WIW Comparison
AMLX vs WIW Comparison
Compare AMLX & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- WIW
- Stock Information
- Founded
- AMLX 2014
- WIW 2004
- Country
- AMLX United States
- WIW United States
- Employees
- AMLX N/A
- WIW N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- WIW Finance Companies
- Sector
- AMLX Health Care
- WIW Finance
- Exchange
- AMLX Nasdaq
- WIW Nasdaq
- Market Cap
- AMLX 481.9M
- WIW 522.5M
- IPO Year
- AMLX 2022
- WIW N/A
- Fundamental
- Price
- AMLX $3.45
- WIW $8.56
- Analyst Decision
- AMLX Buy
- WIW
- Analyst Count
- AMLX 7
- WIW 0
- Target Price
- AMLX $7.60
- WIW N/A
- AVG Volume (30 Days)
- AMLX 921.2K
- WIW 229.9K
- Earning Date
- AMLX 02-20-2025
- WIW 01-01-0001
- Dividend Yield
- AMLX N/A
- WIW 11.14%
- EPS Growth
- AMLX N/A
- WIW N/A
- EPS
- AMLX N/A
- WIW N/A
- Revenue
- AMLX $196,485,000.00
- WIW N/A
- Revenue This Year
- AMLX N/A
- WIW N/A
- Revenue Next Year
- AMLX N/A
- WIW N/A
- P/E Ratio
- AMLX N/A
- WIW N/A
- Revenue Growth
- AMLX N/A
- WIW N/A
- 52 Week Low
- AMLX $1.58
- WIW $8.01
- 52 Week High
- AMLX $19.95
- WIW $9.37
- Technical
- Relative Strength Index (RSI)
- AMLX 38.58
- WIW 64.65
- Support Level
- AMLX $3.02
- WIW $8.23
- Resistance Level
- AMLX $3.67
- WIW $8.60
- Average True Range (ATR)
- AMLX 0.26
- WIW 0.06
- MACD
- AMLX 0.01
- WIW 0.05
- Stochastic Oscillator
- AMLX 37.07
- WIW 88.16
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.